3//SEC Filing
Activist Investing LLC 3
Accession 0001829126-22-014208
CIK 0000910267other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 6:00 PM ET
Size
7.1 KB
Accession
0001829126-22-014208
Insider Transaction Report
Form 3
Holdings
- 1,421,133
Common Stock, par value $0.001
- 43,145(indirect: By LLC)
Common Stock, par value $0.001
Lazar David E.
10% Owner
Holdings
- 1,421,133
Common Stock, par value $0.001
- 43,145(indirect: By LLC)
Common Stock, par value $0.001
Footnotes (3)
- [F1]This Form 3 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
- [F2]Securities of Titan Pharmaceuticals, Inc. (the "Issuer") beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.
- [F3]Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0001817604
Filing Metadata
- Form type
- 3
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 6:00 PM ET
- Size
- 7.1 KB